AcuraStem (acurastem.com) is a patient-based, drug development company pioneering drug discovery and ultimately how treatments are developed for neurodegenerative diseases—including sporadic ALS and FTD.
Enabled by our ground-breaking iNeuroRx® technology platform - AcuraStem has discovered and is now advancing drug candidates that promise to strongly impact disease progression for most patients, including those for whom the genetic cause of their disease is unknown (i.e. sporadic ALS and FTD patients).
The causes of neurodegenerative diseases are complex, and genetically defined forms of disease (e.g. C9ORF72-ALS and FTD) only account for a small percentage of cases. Thus, many scientists didn’t believe it was possible to develop a single effective treatment that could work broadly for all patients. But AcuraStem has shown with its extremely promising therapeutic programs for ALS and FTD that it can be done.
Go to acurastem.com to find out more
Company Details
- Employees
- 33
- Founded
- -
- Address
- 150 North Orange Grove Blvd.,
- Phone
- +1 213-290-0635
- in****@****tem.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- acurastem.com
- HQ
- Pasadena, CA
Acurastem Questions
Acurastem's helpline number is +1 213-290-0635
Acurastem's website is acurastem.com
Acurastem's LinkedIn profile is https://www.linkedin.com/company/acurastem-inc.
Acurastem has
33 employees.
View email and phone details for 33
employees at Acurastem.
Acurastem's industry is
Biotechnology Research
Acurastem's top competitors are
Forest Neurotech,
Qpex Biopharma, Inc.,
Biosapien,
Curve Biosciences,
Kenai Therapeutics,
Cionic,
Avenzo Therapeutics,
Light Horse Therapeutics,
Bitterroot Bio,
Nuvig Therapeutics Inc..
Acurastem's support email address is info@acurastem.com
Acurastem's categories are Biotechnology Research
Acurastem's founding year is 2016
